REDHILL BIOPHARMA LTD. (RDHL) Total assets 2016–2024
REDHILL BIOPHARMA LTD. (RDHL) total assets at each fiscal year-end, per SEC filings.
$18.0MFY2024 · since FY2016: $74.2M → $18.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $18.0M | -21.7% |
| FY2023 | $23.0M | -85.5% |
| FY2022 | $158.9M | -12.3% |
| FY2021 | $181.2M | +0.5% |
| FY2020 | $180.2M | +143.2% |
| FY2019 | $74.1M | +18.7% |
| FY2018 | $62.4M | +8.8% |
| FY2017 | $57.3M | -22.7% |
| FY2016 | $74.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RDHL financial trends
RDHL RevenueRDHL Net incomeRDHL Net marginRDHL Gross profitRDHL Gross marginRDHL Operating incomeRDHL Operating marginRDHL Operating cash flowRDHL Free cash flowRDHL Capital expendituresRDHL Return on equityRDHL Stock buybacksRDHL Dividends paidRDHL Total liabilitiesRDHL Shareholders’ equityRDHL overview →